Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination

NCT03743805 is registered in ClinicalTrials.gov with Prisma Health-Midlands as lead sponsor.

NCT NCT03743805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03743805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination
Lead sponsor
Prisma Health-Midlands
Phase
Phase 1
Overall status
Withdrawn
Start date
January 1, 2019
Completion date
July 21, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anoxic brain injury, brain death, cardiac arrest, narcotic intoxication, sedative intoxication